122 related articles for article (PubMed ID: 35025448)
1. Enhanced Photodynamic Therapy Using the Apohemoglobin-Haptoglobin Complex as a Carrier of Aluminum Phthalocyanine.
Pires IS; O'Boyle QT; Munoz CJ; Savla C; Cabrales P; Palmer AF
ACS Appl Bio Mater; 2020 Jul; 3(7):4495-4506. PubMed ID: 35025448
[TBL] [Abstract][Full Text] [Related]
2. Apohemoglobin-haptoglobin complex attenuates the pathobiology of circulating acellular hemoglobin and heme.
Munoz CJ; Pires IS; Baek JH; Buehler PW; Palmer AF; Cabrales P
Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1296-H1307. PubMed ID: 32302494
[TBL] [Abstract][Full Text] [Related]
3. Novel manufacturing method for producing apohemoglobin and its biophysical properties.
Pires IS; Belcher DA; Hickey R; Miller C; Badu-Tawiah AK; Baek JH; Buehler PW; Palmer AF
Biotechnol Bioeng; 2020 Jan; 117(1):125-145. PubMed ID: 31612988
[TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene glycol) Surface-Conjugated Apohemoglobin as a Synthetic Heme Scavenger.
Pires IS; Savla C; Palmer AF
Biomacromolecules; 2020 Jun; 21(6):2155-2164. PubMed ID: 32186855
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Active Apohemoglobin Heme-Binding Sites via Dicyanohemin Incorporation.
Pires IS; Belcher DA; Palmer AF
Biochemistry; 2017 Oct; 56(40):5245-5259. PubMed ID: 28846391
[TBL] [Abstract][Full Text] [Related]
6. Apohemoglobin-haptoglobin complex alleviates iron toxicity in mice with β-thalassemia via scavenging of cell-free hemoglobin and heme.
Munoz CJ; Pires IS; Jani V; Gopal S; Palmer AF; Cabrales P
Biomed Pharmacother; 2022 Dec; 156():113911. PubMed ID: 36308920
[TBL] [Abstract][Full Text] [Related]
7. Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin.
Belcher DA; Munoz C; Pires IS; Williams AT; Cabrales P; Palmer AF
Blood Adv; 2020 Jun; 4(12):2739-2750. PubMed ID: 32559292
[TBL] [Abstract][Full Text] [Related]
8. Toxic side-effects of diaspirin cross-linked human hemoglobin are attenuated by the apohemoglobin-haptoglobin complex.
Munoz CJ; Lucas D; Martinez J; Ricario M; O'Boyle QT; Pires IS; Palmer AF; Cabrales P
Biomed Pharmacother; 2024 May; 174():116569. PubMed ID: 38603886
[TBL] [Abstract][Full Text] [Related]
9. Studies on hemoglobin tryptophanyl contact residues in the haptoglobin-hemoglobin complex.
Rogard M; Waks M
Eur J Biochem; 1977 Jul; 77(2):367-73. PubMed ID: 891540
[TBL] [Abstract][Full Text] [Related]
10. Zinc-Substituted Hemoglobin-Albumin Cluster as a Porphyrin-Carrier for Enhanced Photodynamic Therapy.
Yamada T; Katsumi M; Ishii K; Komatsu T
Chem Asian J; 2024 Jun; 19(11):e202400257. PubMed ID: 38632107
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Liquid Crystal Nanocarriers for Enhanced Zinc Phthalocyanine-Mediated Photodynamic Therapy.
Nag OK; Naciri J; Erickson JS; Oh E; Delehanty JB
Bioconjug Chem; 2018 Aug; 29(8):2701-2714. PubMed ID: 29990422
[TBL] [Abstract][Full Text] [Related]
12. Core-shell polymeric nanoparticles co-loaded with photosensitizer and organic dye for photodynamic therapy guided by fluorescence imaging in near and short-wave infrared spectral regions.
Chepurna OM; Yakovliev A; Ziniuk R; Nikolaeva OA; Levchenko SM; Xu H; Losytskyy MY; Bricks JL; Slominskii YL; Vretik LO; Qu J; Ohulchanskyy TY
J Nanobiotechnology; 2020 Jan; 18(1):19. PubMed ID: 31973717
[TBL] [Abstract][Full Text] [Related]
13. Study of the Photodynamic Activity of N-Doped TiO₂ Nanoparticles Conjugated with Aluminum Phthalocyanine.
Pan X; Liang X; Yao L; Wang X; Jing Y; Ma J; Fei Y; Chen L; Mi L
Nanomaterials (Basel); 2017 Oct; 7(10):. PubMed ID: 29053580
[TBL] [Abstract][Full Text] [Related]
14. Functional titanium dioxide nanoparticle conjugated with phthalocyanine and folic acid as a promising photosensitizer for targeted photodynamic therapy in vitro and in vivo.
Liang X; Xie Y; Wu J; Wang J; Petković M; Stepić M; Zhao J; Ma J; Mi L
J Photochem Photobiol B; 2021 Feb; 215():112122. PubMed ID: 33433386
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of Hydrophobic Phthalocyanine with Poly(
Liu J; Li J; Zhang Z; Weng Y; Chen G; Yuan B; Yang K; Ma Y
Materials (Basel); 2014 Apr; 7(5):3481-3493. PubMed ID: 28788630
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy.
Jiang Z; Shao J; Yang T; Wang J; Jia L
J Pharm Biomed Anal; 2014 Jan; 87():98-104. PubMed ID: 23746989
[TBL] [Abstract][Full Text] [Related]
17. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
Master AM; Livingston M; Oleinick NL; Sen Gupta A
Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
[TBL] [Abstract][Full Text] [Related]
18. Phthalocyanine-Conjugated Upconversion NaYF
Kostiv U; Patsula V; Noculak A; Podhorodecki A; Větvička D; Poučková P; Sedláková Z; Horák D
ChemMedChem; 2017 Dec; 12(24):2066-2073. PubMed ID: 29105372
[TBL] [Abstract][Full Text] [Related]
19. Novel surface plasmon resonance sensor for the detection of heme at biological levels via highly selective recognition by apo-hemoglobin.
Briand VA; Thilakarathne V; Kasi RM; Kumar CV
Talanta; 2012 Sep; 99():113-8. PubMed ID: 22967529
[TBL] [Abstract][Full Text] [Related]
20. Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'.
Wieder ME; Hone DC; Cook MJ; Handsley MM; Gavrilovic J; Russell DA
Photochem Photobiol Sci; 2006 Aug; 5(8):727-34. PubMed ID: 16886087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
